Alan L. Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alan L. Lin has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Chih-Ko Yeh
Department of Comprehensive Dentistry, University of Texas Health Science Center at San Antonio, San Antonio, USA
3 shared publications - Howard Dang
Developmental Dentistry, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
2 shared publications A. Kamat
STVHCS, ALMD, GRECC, San Antonio, TX 78229 USA
1 shared publicationB. Zhu
UTHSCSA, Dept Comprehens Dent, San Antonio, TX USA
1 shared publication- Bin-Xian Zhang
Department of Comprehensive Dentistry, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900, USA
1 shared publication - Bysani Chandrasekar
Research Service, Southeast Louisiana Veterans Health Care System, New Orleans, LA 70161
1 shared publication
Latest Publications
- Open Access
- 1 June 2015
- Published by Elsevier in BBA Clinical
- Vol. 3, 135-140
Secretion of salivary statherin is compromised in uncontrolled diabetic patients
- 1 June 2015
- Published by Elsevier in BBA Clinical
- Vol. 3, 135-140
Open AccessSecretion of salivary statherin is compromised in uncontrolled diabetic patients
- 20 January 2015
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 116 (3) , 431-437
Early Gene Expression in Salivary Gland After Isoproterenol Treatment
Isoproterenol, a β-adrenergic agonist, has been shown to induce salivary gland hyperplasia. However, the mechanism involved in this pharmacological phenomenon is not well understood. To gain a better understanding of the underlying changes, including genes, networks and pathways altered by isoproterenol, microarray-based gene expression analysis was conducted on rat parotid glands at 10, 30, and 60 min after isoproterenol injection. After isoproterenol treatment, the number of differentially expressed genes was increased in a time-dependent manner. Pathway analysis showed that cell hyperplasia, p38(MAPK), and IGF-1 were the most altered function, network and pathway, respectively. The balanced regulation of up- and down-expression of genes related to cell proliferation/survival may provide a better understanding of the mechanism of isoproterenol-induced parotid gland enlargement without tumor transformation.
- 20 January 2015
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 116 (3) , 431-437
Early Gene Expression in Salivary Gland After Isoproterenol Treatment
Isoproterenol, a β-adrenergic agonist, has been shown to induce salivary gland hyperplasia. However, the mechanism involved in this pharmacological phenomenon is not well understood. To gain a better understanding of the underlying changes, including genes, networks and pathways altered by isoproterenol, microarray-based gene expression analysis was conducted on rat parotid glands at 10, 30, and 60 min after isoproterenol injection. After isoproterenol treatment, the number of differentially expressed genes was increased in a time-dependent manner. Pathway analysis showed that cell hyperplasia, p38(MAPK), and IGF-1 were the most altered function, network and pathway, respectively. The balanced regulation of up- and down-expression of genes related to cell proliferation/survival may provide a better understanding of the mechanism of isoproterenol-induced parotid gland enlargement without tumor transformation.
- 1 January 2012
- Published by Elsevier in Differentiation
- Vol. 83 (1) , 68-76
Cellular signals underlying β-adrenergic receptor mediated salivary gland enlargement
- 1 January 2012
- Published by Elsevier in Differentiation
- Vol. 83 (1) , 68-76
Cellular signals underlying β-adrenergic receptor mediated salivary gland enlargement